Immucell (ICCC) Total Debt (2010 - 2026)

Immucell (ICCC) has reported Total Debt for 17 consecutive years, with $9.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Debt changed 0.11% year-over-year to $9.8 million; the trailing twelve-month figure through Jun 2026 stood at $9.8 million (changed 0.11% YoY), and the FY2025 full-year result was $9.1 million, down 13.66% from the prior year.
• Total Debt rose to $9.8 million in Q2 2026 per ICCC's latest filing, from $9.1 million in the prior quarter.
• Across five years, Total Debt topped out at $13.7 million in Q3 2023 and bottomed at $9.1 million in Q4 2025.
• Historically, Total Debt has averaged $10.8 million across 5 years, with a median of $10.7 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Total Debt soared 31.02% in 2023, then retreated 20.58% in 2024.
• Over 5 years, Total Debt stood at $10.2 million in 2022, then climbed by 17.0% to $12.0 million in 2023, then slipped by 11.95% to $10.5 million in 2024, then decreased by 13.66% to $9.1 million in 2025, then advanced by 7.8% to $9.8 million in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $9.8 million, $9.1 million, and $11.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.